New nerve pain drug shows promise in Year-Long trial
NCT ID NCT05890053
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times
Summary
This study tested the long-term safety and effectiveness of HSK16149 capsules in 301 Chinese patients with peripheral neuralgia (nerve pain) over 52 weeks. Participants had previously completed a shorter study of the same drug. Researchers monitored side effects, lab results, and pain scores to see if the drug remained safe and helpful over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baotou Central Hospital
Baotou, Neimenggu, China
-
Beijing Pinggu District Hospital
Beijing, Beijing Municipality, China
-
Cangzhou People's Hospital
Cangzhou, Hebei, China
-
Emergency General Hospital
Beijing, Beijing Municipality, China
-
Jinan Central Hospital
Jinan, Shandong, China
-
Kaifeng Hospital of Traditional Chinese Medicine
Kaifeng, Henan, China
-
Nanjing First People's Hospital
Nanjing, Jiangsu, China
-
Nanyang First People's Hospital
Nanyang, Henan, China
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
-
Pingxiang People's Hospital
Pingxiang, Jiangxi, China
-
Taizhou First People's Hospital
Taizhou, Zhejiang, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
-
The First Affiliated Hospital of Xi'an Medical University
Xi’an, Shanxi, China
-
The First Hospital of Jilin University
Changchun, Jilin, China
-
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The Second People's Hospital of Yibin
Yibin, Sichuan, China
-
The Third Hospital of Hebei Medical University
Shijiangzhuang, Hebei, China
-
The Three Gorges Hospital Affiliated to Chongqing Medical University
Chongqing, Chongqing Municipality, China
-
Wuhan Central Hospital
Wuhan, Hubei, China
-
Yuncheng Central Hospital
Yuncheng, Shanxi, China
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.